Queensland Needle and Syringe Program (QNSP)
Queensland Government Policy
It is Queensland Government policy to reduce the harms associated with injecting drug use without condoning such drug use. One of the significant harms associated with injecting drug use is the transmission of blood borne viral infections such as HIV/AIDS, hepatitis B (HBV) & C (HCV).
Background to Needle and Syringe Programs
In 1985 the National Drugs Summit identified that injecting drug use posed a significant risk for the transmission of HIV. The supply of sterile injecting equipment to injecting drug users was identified as the appropriate harm reduction strategy.
The Queensland Government introduced Needle and Syringe Programs (NSPs) soon afterwards. The programs supply sterile injecting equipment while incorporating health promotion strategies aimed at improving the health of injecting drug users and reducing risk behaviours associated with injecting drug use. A focus of the program has been developing partnerships with the community to respond to community concerns such as inappropriate disposal of used injecting equipment.
The most significant public health risk associated with injecting drug use is the transmission of blood-borne viral infections (HIV, hepatitis B, and hepatitis C) through the sharing of needles, syringes and other injecting equipment. Exposure to blood-borne viral infection is of concern for:
- injecting drug users (IDUs)
- the sexual partners of IDUs
- the children of IDUs, and the children of their sexual partners, and
- the general population.
It is recognised that the most common means by which blood-borne viral infections are spread in the community is through the sharing of contaminated injecting equipment, unprotected sexual activity and medically acquired infections. It has been clearly established that infection of IDUs constitutes a significant pathway for the spread of blood-borne viral infections to the general community.
It is therefore critical that IDUs have easy, safe and confidential access to sterile injecting equipment.
There is ample evidence that ready access to sterile injecting equipment does not cause an increase either in the number of IDUs or in the prevalence of injecting drug use in the community. In fact, some studies have indicated that the establishment of Needle and Syringe Programs has led to a decrease in the number of injectors by bringing them into contact with treatment services earlier in their drug using careers (Heimer, 1998, Journal of Substance Abuse Treatment, 15(3):183-191).
Making sterile injecting equipment available is a public health strategy that does not condone illicit drug use but rather complements a range of strategies (both public health and treatment oriented) for the reduction of illicit drug use and associated harms.
In order to ensure that both unsafe disposal of used injecting equipment in public spaces and community needle stick injuries are minimised, safe disposal education and disposal facilities are mandatory components of all NSPs.
QNSP Aim and Objectives
Aim
The aim of the Queensland Needle & Syringe Program is to reduce the spread
of blood borne viral infections (BBVI) among injecting drug users (IDUs),
and thereby the general community.
Objectives
The objectives of the program are to:
- increase IDU access to sterile injecting equipment
- provide confidential access to resources that will reduce the risk of transmission of BBVIs among IDUs
- promote the safe disposal of used injecting equipment
- distribute disposal units and provide education about safe, legal disposal
- establish contact with IDUs not normally in contact with health or welfare services
- based on the best available evidence, provide education concerning risk behaviours to IDUs in the context of preventing BBVIs and other infections and to support positive behaviour change
- facilitate the referral of IDUs to drug treatment programs, as appropriate
- encourage HIV, HBV and HCV testing of IDUs and to ensure that appropriate pre & post test counselling is provided
- undertake or support research that meets ethical standards involving the IDU community, and
- provide information and referrals regarding BBVIs, drug use or other health and welfare issues as appropriate
Further information
Resource Development Officer
QNSP
Telephone: +61-7-38963715
Facsimile: +61-7-38963850
Email
This page last updated:
12 August, 2008
Review date: July, 2006
Other languages